Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Home Spirometer Helps Monitor Serious Lung Conditions

By HospiMedica International staff writers
Posted on 30 Apr 2018
A novel hand-held spirometer can help improve self-management of ongoing lung conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis (CF).

The NuvoAir (Stockholm, Sweden) Air Next Spirometer is a sleek, hand held device that measures a host of respiration parameters, including forced expiratory volume (FEV1), the volume of air exhaled during the first second of forced expiration, starting from a full inspiration; forced vital capacity (FVC), the volume of air exhaled during forceful complete expiration, when starting from a full inspiration; FEV1/FVC ratio; and peak expiratory flow (PEF), the maximum speed of expiration, starting from a full inspiration.

To operate the Air Next, the user simply blows into the mouthpiece for a few seconds as guided by the accompanying app, which is connected wirelessly to the device via Bluetooth Low Energy (BLE), a more efficient and cost-effective form of wireless technology. More...
Spirometry results are then instantly forwarded to the smartphone or tablet, where they are displayed in the form of graphs and animations. Air Next is also connected to a secure and compliant cloud that allows the patient to access their data and share it with their health care team.

“NuvoAir has demystified spirometry by bringing it directly into the hands of patients and physicians across the world. It reduces the communication gap between their doctors and health care teams, so improving the quality of care,” said Lorenzo Consoli, CEO of NuvoAir. “In this device we have distilled two years of experience of working with patients to design a device that works easily for them. We believe this will improve the management of many serious lung conditions for the patient, their families and their health care professionals too.”

Spirometry is the most common pulmonary function test. It measures lung function, specifically the volume and/or flow of air that can be inhaled and exhaled. Generally, the patient is asked to take the deepest breath they can, and then exhale into the sensor as hard as possible, for as long as possible, preferably at least six seconds. It is sometimes directly followed by a rapid inhalation (inspiration), in particular when assessing possible upper airway obstruction.

Related Links:
NuvoAir


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.